Desferal (Deferoxamine Mesylate) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Desferal. Always confirm against the full prescribing information.
100 interactions
Ascorbic acid
The risk or severity of Cardiovascular Impairment can be increased when Ascorbic acid is combined with Deferoxamine.
Level 1 evidence
Calcium ascorbate
The risk or severity of Cardiovascular Impairment can be increased when Calcium ascorbate is combined with Deferoxamine.
Level 1 evidence
Abacavir
Abacavir may increase the hepatotoxic activities of Deferoxamine.
Level 2 evidence
Abatacept
Deferoxamine may increase the hepatotoxic activities of Abatacept.
Level 2 evidence
Abemaciclib
Deferoxamine may increase the hepatotoxic activities of Abemaciclib.
Level 2 evidence
Abiraterone
Abiraterone may increase the hepatotoxic activities of Deferoxamine.
Level 2 evidence
Acamprosate
Acamprosate may increase the hepatotoxic activities of Deferoxamine.
Level 2 evidence
Acarbose
Acarbose may increase the hepatotoxic activities of Deferoxamine.
Level 2 evidence
Acebutolol
Deferoxamine may increase the hepatotoxic activities of Acebutolol.
Level 2 evidence
Aceclofenac
Deferoxamine may increase the hepatotoxic activities of Aceclofenac.
Level 2 evidence
Acetaminophen
Acetaminophen may increase the hepatotoxic activities of Deferoxamine.
Level 2 evidence
Acetazolamide
Acetazolamide may increase the hepatotoxic activities of Deferoxamine.
Desferal (Deferoxamine Mesylate) has 492 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Desferal (Deferoxamine Mesylate) has 2 major, 4 moderate, and 486 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Desferal. Always confirm against the full prescribing information.